Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine | Journal of the American Chemical Society
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial | PLOS Medicine
Homologous prime-boost strategy with TgPI-1 improves the immune response and protects highly susceptible mice against chronic Toxoplasma gondii infection - ScienceDirect
Leif Erik Sander on Twitter: "1/6 Our study comparing reactogenicity & immunogenicity of homologous (2xBNT/Pfizer) vs heterologous (AZ/ChAdOx +BNT) vaccination is available https://t.co/kn1V9r7SkC Great team effort @vmcorman #FlorianKurth ...
Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice | PLOS ONE
Vaccunation and Immune Oncology Tool Ad19a/64 Acts as a Prime Reagent in a Two-Step Prime Boost Vaccination Approach - Pharmaceutical Technology
Therapeutic vaccination for treatment of chronic hepatitis B - Cargill - 2021 - Clinical & Experimental Immunology - Wiley Online Library
Prime-Boost Vaccination: Impact on the HIV-1 Vaccine Field - ScienceDirect
Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice | PLOS ONE
![PDF] Jump-starting the immune system: prime-boosting comes of age. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/24c981973d5eff6c4247827df4cc07cad983d12a/2-Figure1-1.png "PDF] Jump-starting the immune system: prime-boosting comes of age. | Semantic Scholar")
PDF] Jump-starting the immune system: prime-boosting comes of age. | Semantic Scholar
Vaccines | Free Full-Text | Characterization of Live-Attenuated Powassan Virus Vaccine Candidates Identifies an Efficacious Prime-Boost Strategy for Mitigating Powassan Virus Disease in a Murine Model
Immunogenicity of heterologous SARS-CoV-2 vector vaccine prime-mRNA vaccine boost vaccination strategy | Immunopaedia
Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques | npj Vaccines
Heterologous Prime-Boost Vaccination with MF59-Adjuvanted H5 Vaccines Promotes Antibody Affinity Maturation towards the Hemagglutinin HA1 Domain and Broad H5N1 Cross-Clade Neutralization | PLOS ONE
Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 - The Lancet Infectious Diseases
Jump-starting the immune system: prime–boosting comes of age: Trends in Immunology
Frontiers | Heterologous Prime-Boost Vaccination Enhances TsPmy's Protective Immunity against Trichinella spiralis Infection in a Murine Model
JCI Insight - Hemagglutinin head-specific responses dominate over stem-specific responses following prime boost with mismatched vaccines
Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice | Signal Transduction and Targeted Therapy
Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study - The Lancet Regional Health – Europe
Cancers | Free Full-Text | Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect
Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses: Molecular Therapy - Oncolytics
A 'mix and match' approach to SARS-CoV-2 vaccination | Nature Medicine
Frontiers | Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
